101140 — InBioGen Co Income Statement
0.000.00%
Last trade - 00:00
IndustrialsHighly SpeculativeMicro Cap
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 9,795 | 10,218 | 10,481 | 10,420 | 6,241 |
Cost of Revenue | |||||
Gross Profit | 1,072 | 812 | 1,959 | 2,359 | 1,276 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 12,512 | 40,160 | 22,384 | 22,938 | 85,147 |
Operating Profit | -2,716 | -29,942 | -11,903 | -12,519 | -78,907 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 13,124 | -45,218 | 111,064 | -136,371 | 19,372 |
Provision for Income Taxes | |||||
Net Income After Taxes | 13,124 | -45,078 | 94,125 | -119,418 | 19,372 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 13,124 | -45,078 | 94,125 | -119,687 | 18,857 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -813 | -45,078 | 94,125 | -119,687 | 18,857 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -157 | -14,032 | 32,664 | -42,245 | 10,827 |
Dividends per Share |